Persson, M. S. et al. The global incidence of bullous pemphigoid: a systematic review and meta‐analysis. Br. J. Dermatol. 186, 414–425 (2022). This systematic review and meta-analysis maps the global distribution of BP.

CAS  PubMed  Google Scholar 

Schmidt, E. & Zillikens, D. Pemphigoid diseases. Lancet 381, 320–332 (2013).

PubMed  Google Scholar 

Egami, S., Yamagami, J. & Amagai, M. Autoimmune bullous skin diseases, pemphigus and pemphigoid. J. Allergy Clin. Immunol. 145, 1031–1047 (2020).

CAS  PubMed  Google Scholar 

Ständer, S., Schmidt, E., Zillikens, D., Ludwig, R. J. & Kridin, K. Immunological features and factors associated with mucocutaneous bullous pemphigoid–a retrospective cohort study. J. Dtsch Dermatol. Ges. 19, 1289–1295 (2021).

PubMed  Google Scholar 

Kridin, K. & Bergman, R. Assessment of the prevalence of mucosal involvement in bullous pemphigoid. JAMA Dermatol. 155, 166–171 (2019).

PubMed  PubMed Central  Google Scholar 

Patsatsi, A. et al. Quality of life in Greek patients with autoimmune bullous diseases assessed with ABQOL and TABQOL indexes. Acta Derm. Venereol. 97, 1145–1147 (2017).

PubMed  Google Scholar 

Wijayanti, A. et al. The reliability, validity and responsiveness of two disease scores (BPDAI and ABSIS) for bullous pemphigoid: which one to use? Acta Derm. Venereol. 97, 24–31 (2017).

PubMed  Google Scholar 

Ben Mordehai, Y. et al. Characteristics of patients with bullous pemphigoid: comparison of classic bullous pemphigoid to non‐bullous pemphigoid. J. Eur. Acad. Dermatol. Venereol. 34, 161–165 (2020).

PubMed  Google Scholar 

Karakioulaki, M., Eyerich, K. & Patsatsi, A. Advancements in bullous pemphigoid treatment: a comprehensive pipeline update. Am. J. Clin. Dermatol. 25, 195–212 (2024).

PubMed  Google Scholar 

Persson, M. et al. Incidence, prevalence and mortality of bullous pemphigoid in England 1998–2017: a population‐based cohort study. Br. J. Dermatol. 184, 68–77 (2021).

CAS  PubMed  Google Scholar 

Van Beek, N. et al. Incidence of pemphigoid diseases in Northern Germany in 2016–first data from the Schleswig‐Holstein Registry of Autoimmune Bullous Diseases. J. Eur. Acad. Dermatol. Venereol. 35, 1197–1202 (2021).

PubMed  Google Scholar 

Baican, A. et al. Pemphigus vulgaris is the most common autoimmune bullous disease in Northwestern Romania. Int. J. Dermatol. 49, 768–774 (2010).

PubMed  Google Scholar 

Försti, A.-K. et al. Psychiatric and neurological disorders are associated with bullous pemphigoid–a nationwide Finnish Care Register study. Sci. Rep. 6, 37125 (2016).

PubMed  PubMed Central  Google Scholar 

Bertram, F., Bröcker, E. B., Zillikens, D. & Schmidt, E. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J. Dtsch Dermatol. Ges. 7, 434–439 (2009).

PubMed  Google Scholar 

Joly, P. et al. Incidence and mortality of bullous pemphigoid in France. J. Invest. Dermatol. 132, 1998–2004 (2012).

CAS  PubMed  Google Scholar 

Försti, A. K., Jokelainen, J., Timonen, M. & Tasanen, K. Increasing incidence of bullous pemphigoid in Northern Finland: a retrospective database study in Oulu University Hospital. Br. J. Dermatol. 171, 1223–1226 (2014).

PubMed  Google Scholar 

Kridin, K. & Ludwig, R. J. The growing incidence of bullous pemphigoid: overview and potential explanations. Front. Med. 5, 220 (2018).

Google Scholar 

Langan, S. et al. Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study. BMJ 337, a180 (2008).

CAS  PubMed  Google Scholar 

Rzany, B. et al. Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age. Arch. Dermatol. 138, 903–908 (2002).

PubMed  Google Scholar 

Nanda, A., Al‐Saeid, K., Al‐Sabah, H., Dvorak, R. & Alsaleh, Q. Clinicoepidemiological features and course of 43 cases of bullous pemphigoid in Kuwait. Clin. Exp. Dermatol. 31, 339–342 (2006).

CAS  PubMed  Google Scholar 

Lee, J. H. & Kim, S.-C. Mortality of patients with bullous pemphigoid in Korea. J. Am. Acad. Dermatol. 71, 676–683 (2014).

PubMed  Google Scholar 

Junga, M., Kippesb, W., Messer, G., Zillikens, D. & Rzany, B. Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J. Am. Acad. Dermatol. 41, 266–268 (1999).

Google Scholar 

Parker, S. R. et al. Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States. J. Am. Acad. Dermatol. 59, 582–588 (2008).

PubMed  Google Scholar 

Kridin, K. & Bergman, R. Ethnic variations in the epidemiology of bullous pemphigoid in Israel. Int. J. Dermatol. 57, 34–39 (2018).

PubMed  Google Scholar 

Cai, S. et al. Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre. Br. J. Dermatol. 170, 1319–1326 (2014).

CAS  PubMed  Google Scholar 

Langan, S. M., Groves, R. W. & West, J. The relationship between neurological disease and bullous pemphigoid: a population-based case–control study. J. Invest. Dermatol. 131, 631–636 (2011).

CAS  PubMed  Google Scholar 

Chen, Y. et al. Comorbidity profiles among patients with bullous pemphigoid: a nationwide population‐based study. Br. J. Dermatol. 165, 593–599 (2011).

CAS  PubMed  Google Scholar 

Försti, A.-K., Jokelainen, J., Timonen, M. & Tasanen, K. Risk of death in bullous pemphigoid: a retrospective database study in Finland. Acta Derm. Venereol. 96, 758–761 (2016).

PubMed  Google Scholar 

Kibsgaard, L. et al. Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population‐based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid. Br. J. Dermatol. 176, 1486–1491 (2017).

CAS  PubMed  Google Scholar 

Lai, N. M. et al. Catheter impregnation, coating or bonding for reducing central venous catheter‐related infections in adults. Cochrane Database Syst. Rev. 3, CD007878 (2016).

PubMed  Google Scholar 

Schneeweiss, M. C., Merola, J. F., Wyss, R., Silverberg, J. I. & Mostaghimi, A. Venous thromboembolism in patients with bullous pemphigoid. JAMA Dermatol. 159, 750–756 (2023).

PubMed  PubMed Central  Google Scholar 

Bastuji-Garin, S. et al. Risk factors for bullous pemphigoid in the elderly: a prospective case–control study. J. Invest. Dermatol. 131, 637–643 (2011).

CAS  PubMed  Google Scholar 

Tuusa, J. et al. BP180 autoantibodies target different epitopes in multiple sclerosis or Alzheimer’s disease than in bullous pemphigoid. J. Invest. Dermatol. 139, 293–299 (2019).

CAS  PubMed  Google Scholar 

Schulze, F. et al. Malignancies in pemphigus and pemphigoid diseases. J. Invest. Dermatol. 135, 1445–1447 (2015).

CAS  PubMed  Google Scholar 

Atzmony, L. et al. Association of bullous pemphigoid with malignancy: a systematic review and meta-analysis. J. Am. Acad. Dermatol. 77, 691–699 (2017).

PubMed  Google Scholar 

Lucariello, R. J., Villablanca, S. E., Mascaro, J. M. Jr & Reichel, M. Association between bullous pemphigoid and malignancy: a meta‐analysis. Australas. J. Dermatol. 59, 253–260 (2018).

PubMed  Google Scholar 

Albadri, Z., Thorslund, K., Häbel, H., Seifert, O. & Grönhagen, C. Increased risk of squamous cell carcinoma of the skin and lymphoma among 5,739 patients with bullous pemphigoid: a Swedish nationwide cohort study. Acta Derm. Venereol. 100, adv00289 (2020).

CAS  PubMed  Google Scholar 

Kridin, K., Hammers, C. M., Ludwig, R. J. & Cohen, A. D. Risk of solid malignancies in bullous pemphigoid: a large‐scale population‐based cohort study. J. Dermatol. 48, 317–323 (2021).

CAS  PubMed  Google Scholar 

Varpuluoma, O., Jokelainen, J., Huilaja, L. & Tasanen, K. Solid and hematological malignancies in patients with bullous pemphigoid: a national cohort study. J. Am. Acad. Dermatol. 90, 399–401 (2024).

PubMed  Google Scholar 

Varpuluoma, O. et al. Vildagliptin significantly increases the risk of bullous pemphigoid: a Finnish nationwide registry study. J. Invest. Dermatol. 138, 1659–1661 (2018).

CAS  PubMed  Google Scholar 

Plaquevent, M. et al. Higher frequency of dipeptidyl peptidase-4 inhibitor intake in bullous pemphigoid patients than in the French general population. J. Invest. Dermatol. 139, 835–841 (2019).

CAS  PubMed  Google Scholar 

Kridin, K. & Bergman, R. Association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors in patients with diabetes: estimating the risk of the new agents and characterizing the patients. JAMA Dermatol. 154, 1152–1158 (2018).

PubMed  PubMed Central  Google Scholar 

Lee, S. G., Lee, H. J., Yoon, M. S. & Kim, D. H. Association of di